Prosecution Insights
Last updated: October 27, 2026

Jessica Danielle Parisi, USPTO Patent Examiner

Listed by the USPTO as PARISI, JESSICA DANIELLE

Tech Center 1600 • Art Units: 1634 1637 1639 1675 1682 1684

This examiner grants 75% of resolved cases

Analysis

This record covers 100 resolved cases in Tech Center 1600 and Art Unit 1634. The allowance rate is 75.0%, and the median time to allowance is 1281 days. Interview lift is 33.5%, indicating that interviews are associated with a meaningful improvement in allowance outcomes.

The listed companies are 10x Genomics Inc., Fred Hutchinson Cancer Research Center, and Arc Bio LLC. The listed firms are WILSON SONSINI GOODRICH & ROSATI, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, and BakerHostetler. Practitioners may reasonably treat interview preparation as an important component of prosecution, while planning for extended pendency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.0%
Allow Rate
+15.0% vs TC avg
152
Total Applications
+33.5%
Interview Lift
1281
Avg Prosecution Days
Based on 100 resolved cases, 2023–2026

Rejection Statute Breakdown

5.6%
§101 Eligibility
25.8%
§102 Novelty
35.8%
§103 Obviousness
22.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17922049 DNA END REPAIR REAGENT AND KIT THEREOF, DNA LIBRARY CONSTRUCTION KIT, AND METHOD FOR CONSTRUCTING DNA LIBRARY Final Rejection BOE TECHNOLOGY GROUP CO., LTD.
17393994 IN-SITU SPATIAL TRANSCRIPTOMICS AND PROTEOMICS Non-Final OA Massachusetts Institute of Technology
18525142 METHODS AND SYSTEMS FOR ENGINEERING ANTIBODIES, AND ANTIGEN-BINDING FRAGMENTS THEREOF, TO HAVE ALTERED CHARACTERISTICS Non-Final OA 10x Genomics, Inc.
18511791 METHODS FOR ANALYZING NUCLEIC ACIDS Non-Final OA 10X Genomics, Inc.
17773333 A METHOD TO PREPARE PERSONALIZED TARGET-IRRELEVANT GUIDE RNA POOL FOR CRISPR Final Rejection Siemens Healthcare Diagnostics, Inc.
17098912 MAGNETIC CAPTURE BEAD MEDIATED MOLECULAR BARCODING OF NUCLEIC ACID TARGETS IN SINGLE PARTICLES AND COMPOSITIONS FOR USE IN THE SAME Non-Final OA Becton, Dickinson and Company
17620605 METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF Final Rejection Board of Regents, The University of Texas System
18567989 ORTHOGONAL HYBRIDIZATION Non-Final OA Illumina, Inc.
18190330 LABELED AVIDIN AND METHODS FOR SEQUENCING Final Rejection Illumina, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jessica Danielle Parisi's allowance rate?

75.0% of resolved applications examined by Jessica Danielle Parisi were allowed (100 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.

Does an interview help with examiner Jessica Danielle Parisi?

This examiner's interview lift is +33.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jessica Danielle Parisi take to allow a patent?

Applications allowed by Jessica Danielle Parisi took 1,281 days on average from filing to allowance.

Which art unit does examiner Jessica Danielle Parisi work in?

Jessica Danielle Parisi examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month